[[{“value”:”
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Cannabix Technologies (CSE: BLO) (OTC PINK: BLOZF) has signed a memorandum of understanding (MOU) with AlcoPro Inc. of Knoxville, TN, to collaborate on marketing the Cannabix Marijuana Breathalyzer (CMB) technology in the United States. As part of the initial agreement, AlcoPro will feature the CMB hardware in its 2025 product catalogue, which reaches over 70,000 businesses globally.
AlcoPro, established in 1982, is a leading distributor of drug and alcohol testing instruments. The MOU aims to establish preliminary marketing exposure for the CMB to AlcoPro’s customers, assess market interest, and work towards a future distribution agreement. Cannabix has recently upgraded its Breath Collection Unit (BCU), a key hardware component used for portable detection of delta-9 THC in breath, and is advancing its validation work in the United States.
Cannabix Technologies (CSE: BLO) (OTC PINK: BLOZF) ha firmato un memorandum d’intesa (MOU) con AlcoPro Inc. di Knoxville, TN, per collaborare nella commercializzazione della tecnologia Cannabix Marijuana Breathalyzer (CMB) negli Stati Uniti. Come parte dell’accordo iniziale, AlcoPro includerà l’hardware CMB nel suo catalogo prodotti 2025, che raggiunge oltre 70.000 aziende a livello globale.
AlcoPro, fondata nel 1982, è un distributore leader di strumenti per test di droga e alcol. L’MOU mira a stabilire un’esposizione di marketing preliminare per il CMB ai clienti di AlcoPro, valutare l’interesse del mercato e lavorare verso un futuro accordo di distribuzione. Cannabix ha recentemente aggiornato la sua Breath Collection Unit (BCU), un componente hardware fondamentale utilizzato per la rilevazione portatile del delta-9 THC nel respiro, e sta avanzando nel suo lavoro di validazione negli Stati Uniti.
Cannabix Technologies (CSE: BLO) (OTC PINK: BLOZF) ha firmado un memorando de entendimiento (MOU) con AlcoPro Inc. de Knoxville, TN, para colaborar en la comercialización de la tecnología Cannabix Marijuana Breathalyzer (CMB) en los Estados Unidos. Como parte del acuerdo inicial, AlcoPro incluirá el hardware CMB en su catálogo de productos de 2025, que llega a más de 70,000 empresas a nivel mundial.
AlcoPro, fundada en 1982, es un distribuidor líder de instrumentos para pruebas de drogas y alcohol. El MOU tiene como objetivo establecer una exposición de marketing preliminar para el CMB a los clientes de AlcoPro, evaluar el interés del mercado y trabajar hacia un futuro acuerdo de distribución. Cannabix ha actualizado recientemente su Breath Collection Unit (BCU), un componente clave de hardware utilizado para la detección portátil de delta-9 THC en el aliento, y está avanzando en su trabajo de validación en los Estados Unidos.
캐나빅스 기술(Cannabix Technologies) (CSE: BLO) (OTC PINK: BLOZF)는 TN주 녹스빌에 있는 알코프로(AlcoPro Inc.)와 미국에서 캐나빅스 대마초 호흡 측정기(CMB) 기술의 마케팅을 협력하기 위한 양해각서를 체결했습니다. 초기 계약의 일환으로, 알코프로는 2025년 제품 카탈로그에 CMB 하드웨어를 포함할 예정이며, 이는 전 세계 70,000개 이상의 기업에 도달합니다.
1982년 설립된 알코프로는 약물 및 알코올 테스트 기기의 주요 유통업체입니다. 이 양해각서는 알코프로의 고객에게 CMB의 초기 마케팅 노출을 설정하고 시장의 관심을 평가하며 향후 유통 계약을 위한 작업을 목표로 합니다. 캐나빅스는 최근 호흡에서 델타-9 THC를 포터블 감지하는 데 사용되는 핵심 하드웨어 구성 요소인 호흡 수집 장치(Breath Collection Unit, BCU)를 업그레이드했으며, 미국에서 검증 작업을 진행 중입니다.
Cannabix Technologies (CSE: BLO) (OTC PINK: BLOZF) a signé un mémorandum d’accord (MOU) avec AlcoPro Inc. de Knoxville, TN, pour collaborer à la commercialisation de la technologie Cannabix Marijuana Breathalyzer (CMB) aux États-Unis. Dans le cadre de l’accord initial, AlcoPro inclura le matériel CMB dans son catalogue de produits de 2025, qui atteint plus de 70 000 entreprises dans le monde.
AlcoPro, fondée en 1982, est un distributeur leader d’instruments de test de drogue et d’alcool. Le MOU vise à établir une exposition préliminaire au marketing pour le CMB auprès des clients d’AlcoPro, à évaluer l’intérêt du marché et à travailler vers un futur accord de distribution. Cannabix a récemment mis à jour son Breath Collection Unit (BCU), un composant matériel clé utilisé pour la détection portative du delta-9 THC dans l’haleine, et progresse dans son travail de validation aux États-Unis.
Cannabix Technologies (CSE: BLO) (OTC PINK: BLOZF) hat ein Memorandum of Understanding (MOU) mit AlcoPro Inc. aus Knoxville, TN, unterzeichnet, um bei der Vermarktung der Cannabix Marijuana Breathalyzer (CMB) Technologie in den Vereinigten Staaten zusammenzuarbeiten. Im Rahmen der ersten Vereinbarung wird AlcoPro das CMB-Hardware in seinen Produktkatalog 2025 aufnehmen, der über 70.000 Unternehmen weltweit erreicht.
AlcoPro, gegründet 1982, ist ein führender Distributor von Drogen- und Alkoholtestgeräten. Das MOU zielt darauf ab, eine erste Marketingpräsenz für das CMB bei AlcoPros Kunden zu schaffen, das Marktinteresse zu bewerten und auf einen zukünftigen Vertriebsvertrag hinzuarbeiten. Cannabix hat kürzlich seine Breath Collection Unit (BCU) aktualisiert, eine wichtige Hardwarekomponente zur portablen Erkennung von Delta-9 THC im Atem, und treibt seine Validierungsarbeiten in den Vereinigten Staaten voran.
Positive
Strategic marketing partnership with established distributor AlcoPro reaching 70,000+ potential customers
Recent technical upgrade to Breath Collection Unit (BCU) hardware
Progress in validation testing for marijuana breathalyzer technology
Negative
MOU is preliminary and non-binding
No immediate revenue generation from the agreement
Distribution agreement still pending
01/24/2025 – 08:45 AM
VANCOUVER, British Columbia, Jan. 24, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it has entered a memorandum of understanding (“MOU”) with AlcoPro Inc. (“AlcoPro”) of Knoxville, TN, to begin collaborating on marketing efforts for the Cannabix Marijuana Breathalyzer (“CMB”) technology in the United States. In the short-term, AlcoPro will include the CMB hardware in its upcoming 2025 product catalogue, mailed to over 70,000 businesses in U.S. and globally. AlcoPro is a well-established distributor and leading supplier of drug and alcohol testing instruments, kits, and supplies for professional use, since 1982.
The objective of the MOU is to establish preliminary marketing exposure of the CMB to AlcoPro customers, gauge interest and work towards a future distribution agreement. Cannabix recently upgraded its Breath Collection Unit (“BCU”) – a critical hardware tool used for portable collection of delta-9 THC in breath (image below). Cannabix is quickly advancing its marijuana breathalyzer technology, with key validation work well underway in the United States.
Cannabix Breath Collection Unit (“BCU”) with Breath Cartridge technology.
Rav Mlait, CEO of Cannabix stated, “We are very pleased to be building a relationship with AlcoPro to begin preliminary marketing of our technology. The Company continues to advance its marijuana breathalyzer technology with key scientific validations and testing which are well underway.”
Brian Terry, Director of Business Development of AlcoPro stated, “We are thrilled to establish a relationship with Cannabix Technologies, broadening our focus from providing physical testing tools to embracing innovative technologies that address the growing need for accurate and reliable THC detection. As workplace safety challenges evolve, it’s critical to stay at the forefront of solutions that proactively mitigate risks and ensure a safer environment for employees.”
About AlcoPro, Inc.
Since 1982, AlcoPro has been a trusted leader in drug and alcohol testing solutions for employers, healthcare professionals, law enforcement, and substance abuse specialists. Known for reliable instruments like market-leading breathalyzers, AlcoPro also offers innovative online training with interactive tools to enhance knowledge retention. With a comprehensive product catalog, easy online ordering, and expert support, AlcoPro makes workplace testing simple, accurate, and professional. Learn more at www.AlcoPro.com.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a developer of marijuana and alcohol breathalyzer technologies for law enforcement, workplaces and laboratories. Cannabix is developing delta-9 THC and alcohol screening devices. Delta-9 THC is the primary psychoactive ingredient in cannabis. Breath testing for delta-9 THC would allow employers and law enforcement to identify recent marijuana use. Cannabix is the developer of its Breath Logix Series of breath alcohol detection devices for employers and a range of other settings.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEO
Cannabix Technologies Inc.
For further information, contact the Company at info@cannabixtechnologies.com.
Cautionary Statement Regarding Forward-Looking Statements
This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “anticipates,” “plan,” “continue,” “expect,” “project,” “intend,” “believe,” “anticipate,” “estimate,” “may,” “will,” “potential,” “proposed,” “positioned” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements relating to: the achievement of any or all of the goals and aims of an “MOU” or partnerships as described in this news release; final development of a commercial or prototype product(s); the successful trial or pilot of company technologies; the commercialization of the Company’s products; the negotiation and potential entry into additional agreements with existing and new partners; and the completion of future financings. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Important factors that could cause actual results to differ materially from those expressed in the forward-looking information include (but are note limited to): adverse market conditions; risks regarding protection of proprietary technology; the ability of the Company to complete future financings; the ability of the Company to develop and market its future product; risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition; that partners may not complete all or any of the milestones as contemplated strategic partnership agreements; that the CSE may not approve the issuance of the securities; that the Company’s development of breathalyzer technology will provide any benefit to the Company; there is no assurance that any proposed new products will be built, will be successful in beta testing or clinical trials; there is no assurance that the Company will enter into any partnerships to advance any of its corporate initiatives or technologies; there is no assurance that any “patent pending” or “provisional patents” technologies licensed by the Company or owned by the Company will receive patent status by regulatory authorities; the Company is not currently selling breathalyzers and there is no assurance that the Company ever will; and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2f91b399-d164-47d1-a74c-d9bde9f1f867
What is the significance of Cannabix’s MOU with AlcoPro for BLOZF stock?
The MOU provides BLOZF access to AlcoPro’s extensive distribution network of 70,000+ businesses, potentially expanding market reach for their marijuana breathalyzer technology and creating future revenue opportunities.
How many businesses will the BLOZF marijuana breathalyzer be marketed to through AlcoPro’s 2025 catalog?
The Cannabix Marijuana Breathalyzer will be marketed to over 70,000 businesses globally through AlcoPro’s 2025 product catalog.
What recent technical improvements has BLOZF made to its marijuana breathalyzer?
BLOZF has recently upgraded its Breath Collection Unit (BCU), which is a critical hardware tool used for portable collection of delta-9 THC in breath.
When will BLOZF’s marijuana breathalyzer be included in AlcoPro’s product catalog?
The Cannabix Marijuana Breathalyzer will be included in AlcoPro’s upcoming 2025 product catalog.
“}]] Cannabix Technologies signs MOU with AlcoPro to feature its marijuana breathalyzer in 2025 catalog, reaching 70,000+ global businesses. Strategic move advances US market entry. Read More
